In recent years, the intricate relationship between DNA repair mechanisms and cancer development has come into sharper focus, spotlighting a...

In recent years, the landscape of multiple myeloma (MM) diagnosis and treatment has undergone a profound transformation, largely driven by...

The landscape of cancer diagnostics has witnessed transformative advancements, particularly in the realm of human epidermal growth factor receptor 2...

In a groundbreaking advancement poised to reshape the therapeutic landscape of advanced gastric cancer, researchers have unveiled compelling evidence supporting...

In an era where early cancer detection defines the edge of clinical success, a groundbreaking study published in BMC Cancer...

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most formidable challenges in oncology, persistently defying decades of therapeutic innovation and...

The intricate relationship between aging and cancer has long perplexed scientists and clinicians alike. While cancer is predominantly recognized as...

The landscape of non-small cell lung cancer (NSCLC) treatment has undergone a radical transformation in recent years, driven by advances...

In a significant advancement for the treatment of advanced cutaneous squamous cell carcinoma (cSCC), a phase II clinical trial spearheaded...

In a significant advancement in the treatment of advanced cutaneous squamous cell carcinoma (cSCC), a randomized phase II clinical trial...